186 related articles for article (PubMed ID: 34975314)
1. Dysregulation of Transglutaminase type 2 through GATA3 defines aggressiveness and Doxorubicin sensitivity in breast cancer.
Aguiari G; Crudele F; Taccioli C; Minotti L; Corrà F; Keillor JW; Grassilli S; Cervellati C; Volinia S; Bergamini CM; Bianchi N
Int J Biol Sci; 2022; 18(1):1-14. PubMed ID: 34975314
[TBL] [Abstract][Full Text] [Related]
2. The Motility and Mesenchymal Features of Breast Cancer Cells Correlate with the Levels and Intracellular Localization of Transglutaminase Type 2.
Bianchi N; Brugnoli F; Grassilli S; Bourgeois K; Keillor JW; Bergamini CM; Aguiari G; Volinia S; Bertagnolo V
Cells; 2021 Nov; 10(11):. PubMed ID: 34831282
[TBL] [Abstract][Full Text] [Related]
3. Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-кB target genes in human breast cancer.
Dalmases A; González I; Menendez S; Arpí O; Corominas JM; Servitja S; Tusquets I; Chamizo C; Rincón R; Espinosa L; Bigas A; Eroles P; Furriol J; Lluch A; Rovira A; Albanell J; Rojo F
Oncotarget; 2014 Jan; 5(1):196-210. PubMed ID: 24344116
[TBL] [Abstract][Full Text] [Related]
4. The transglutaminase 2 gene is aberrantly hypermethylated in glioma.
Dyer LM; Schooler KP; Ai L; Klop C; Qiu J; Robertson KD; Brown KD
J Neurooncol; 2011 Feb; 101(3):429-40. PubMed ID: 20596752
[TBL] [Abstract][Full Text] [Related]
5. Metabolic characterisation of transglutaminase 2 inhibitor effects in breast cancer cell lines.
Gallo M; Ferrari E; Terrazzan A; Brugnoli F; Spisni A; Taccioli C; Aguiari G; Trentini A; Volinia S; Keillor JW; Bergamini CM; Bianchi N; Pertinhez TA
FEBS J; 2023 Nov; 290(22):5411-5433. PubMed ID: 37597264
[TBL] [Abstract][Full Text] [Related]
6. The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer.
Ai L; Kim WJ; Demircan B; Dyer LM; Bray KJ; Skehan RR; Massoll NA; Brown KD
Carcinogenesis; 2008 Mar; 29(3):510-8. PubMed ID: 18174247
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA La-related RNA-binding protein 4 correlates with reduced tumor stage, as well as better prognosis, and promotes chemosensitivity to doxorubicin in breast cancer.
Zhang X; Su X; Guo Z; Jiang X; Li X
J Clin Lab Anal; 2020 Jul; 34(7):e23272. PubMed ID: 32187743
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel human receptor activator of nuclear factor-kB isoforms generated through alternative splicing: implications in breast cancer cell survival and migration.
Papanastasiou AD; Sirinian C; Kalofonos HP
Breast Cancer Res; 2012 Jul; 14(4):R112. PubMed ID: 22824341
[TBL] [Abstract][Full Text] [Related]
9. Gain-of-function p53 mutant with 21-bp deletion confers susceptibility to multidrug resistance in MCF-7 cells.
Tsou SH; Hou MH; Hsu LC; Chen TM; Chen YH
Int J Mol Med; 2016 Jan; 37(1):233-42. PubMed ID: 26572087
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA lnc-LOC645166 promotes adriamycin resistance via NF-κB/GATA3 axis in breast cancer.
Zheng R; Jia J; Guan L; Yuan H; Liu K; Liu C; Ye W; Liao Y; Lin S; Huang O
Aging (Albany NY); 2020 May; 12(10):8893-8912. PubMed ID: 32461377
[TBL] [Abstract][Full Text] [Related]
11. Metformin prevention of doxorubicin resistance in MCF-7 and MDA-MB-231 involves oxidative stress generation and modulation of cell adaptation genes.
Marinello PC; Panis C; Silva TNX; Binato R; Abdelhay E; Rodrigues JA; Mencalha AL; Lopes NMD; Luiz RC; Cecchini R; Cecchini AL
Sci Rep; 2019 Apr; 9(1):5864. PubMed ID: 30971831
[TBL] [Abstract][Full Text] [Related]
12. GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition.
Yan W; Cao QJ; Arenas RB; Bentley B; Shao R
J Biol Chem; 2010 Apr; 285(18):14042-51. PubMed ID: 20189993
[TBL] [Abstract][Full Text] [Related]
13. Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer.
Tekedereli I; Alpay SN; Tavares CD; Cobanoglu ZE; Kaoud TS; Sahin I; Sood AK; Lopez-Berestein G; Dalby KN; Ozpolat B
PLoS One; 2012; 7(7):e41171. PubMed ID: 22911754
[TBL] [Abstract][Full Text] [Related]
14. Ataxia-Telangiectasia, Mutated (ATM)/Nuclear Factor κ light chain enhancer of activated B cells (NFκB) signaling controls basal and DNA damage-induced transglutaminase 2 expression.
Ai L; Skehan RR; Saydi J; Lin T; Brown KD
J Biol Chem; 2012 May; 287(22):18330-41. PubMed ID: 22493284
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer.
Mehta K; Fok J; Miller FR; Koul D; Sahin AA
Clin Cancer Res; 2004 Dec; 10(23):8068-76. PubMed ID: 15585642
[TBL] [Abstract][Full Text] [Related]
16. CIP2A silencing alleviates doxorubicin resistance in MCF7/ADR cells through activating PP2A and autophagy.
Zhu Z; Wei Z
Clin Transl Oncol; 2021 Aug; 23(8):1542-1548. PubMed ID: 33948919
[TBL] [Abstract][Full Text] [Related]
17. GATA3 mediates doxorubicin resistance by inhibiting CYB5R2-catalyzed iron reduction in breast cancer cells.
Zhu Z; Shen H; Xu J; Fang Z; Wo G; Ma Y; Yang K; Wang Y; Yu Q; Tang JH
Drug Resist Updat; 2023 Jul; 69():100974. PubMed ID: 37230023
[TBL] [Abstract][Full Text] [Related]
18. The role of Kif4A in doxorubicin-induced apoptosis in breast cancer cells.
Wang H; Lu C; Li Q; Xie J; Chen T; Tan Y; Wu C; Jiang J
Mol Cells; 2014 Nov; 37(11):812-8. PubMed ID: 25377255
[TBL] [Abstract][Full Text] [Related]
19. NFκBP65 transcription factor modulates resistance to doxorubicin through ABC transporters in breast cancer.
Velaei K; Samadi N; Soltani S; Barazvan B; Soleimani Rad J
Breast Cancer; 2017 Jul; 24(4):552-561. PubMed ID: 27878697
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomics Studies Reveal Functions of Transglutaminase 2 in Breast Cancer Cells Using Membrane Permeable and Impermeable Inhibitors.
Ancona P; Trentini A; Terrazzan A; Grassilli S; Navals P; Gates EWJ; Rosta V; Cervellati C; Bergamini CM; Pignatelli A; Keillor JW; Taccioli C; Bianchi N
J Mol Biol; 2024 May; 436(10):168569. PubMed ID: 38604527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
